Clinical trials
Phase 2 trials in Norway with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 8 |
| Haukeland University Hospital | 3 |
| National Research Centre of Complementary and Alternative Medicine, Norway | 2 |
| University Hospital, Aker | 2 |
| University of Bergen | 2 |
| Vestre Viken Hospital Trust | 2 |
| Alvine Pharmaceuticals Inc. | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 3 |
| Lung Neoplasms | 3 |
| Recurrence | 3 |
| Heart Failure | 2 |
| Insulin Resistance | 2 |
| Multiple Myeloma | 2 |
| Addison Disease | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Anxiety Disorders | 1 |
| Autism Spectrum Disorder | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.